Erectile Dysfunction Drugs Market Report

Erectile Dysfunction Drugs Market Analysis By Product (Viagra, Levitra/Staxyn, Stendra/Spedra, Zydena, Vitaros), And Segment Forecasts To 2022

  • Published Date: Jul, 2016
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-604-2
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 70

Table of Content

Chapter 1. Methodology and Scope
                    1.1. Research methodology
                    1.2. Research scope & assumption
                    1.3. List of data sources
Chapter 2. Executive Summary
                    2.1. Erectile Dysfunction Drugs - Industry Summary and Key Buying Criteria, 2012 - 2022
Chapter 3. Erectile Dysfunction Drugs Industry Outlook
                    3.1. Erectile dysfunction drugs market segmentation
                    3.2. Erectile dysfunction drugs market size and growth prospects, 2012-2022
                    3.3. Erectile dysfunction drugs market dynamics
                       3.3.1. Market driver analysis
                       3.3.2. Market restraint analysis
                    3.4. Key opportunities prioritized
                    3.5. Industry analysis - Porter's
                    3.6. Erectile dysfunction drugs: Company market share, 2014
                    3.7. Erectile dysfunction drugs market PESTEL analysis, 2014
Chapter 4. Erectile Dysfunction Drugs Product Outlook
                    4.1. Erectile dysfunction drugs market share by product, 2014 & 2022
                       4.1.1. Viagra (sildenafil citrate) market estimates and forecasts, 2012 - 2022 (USD Million)
                       4.1.2. Cialis (Tadalafil) market estimates and forecasts, 2012 - 2022 (USD Million)
                       4.1.3. Levitra/Staxyn (vardenafil) market estimates and forecasts, 2012 - 2022 (USD Million)
                       4.1.4. Stendra/Spedra (avanafil) estimates and forecasts, 2012 - 2022 (USD Million)
                       4.1.5. Zydena (udenafil) market estimates and forecasts, 2012 - 2022 (USD Million)
                       4.1.6. Vitaros (Alprostadil Cream) market estimates and forecasts, 2012 - 2022 (USD Million)
                       4.1.7. Other drugs market estimates and forecasts, 2012 - 2022 (USD Million)
Chapter 5. Erectile Dysfunction Drugs Regional Outlook
                    5.1. North America
                       5.1.1. North America market, by product, 2012 - 2022 (USD Million)
                    5.2. Europe
                       5.2.1. Europe market, by product, 2012 - 2022 (USD Million)
                    5.3. Asia Pacific
                       5.3.1. Asia Pacific market, by product, 2012 - 2022 (USD Million)
                    5.4. Latin America
                       5.4.1. Latin America market, by product, 2012 - 2022 (USD Million)
                    5.5. MEA
                       5.5.1. MEA market, by product, 2012 - 2022 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Apricus Biosciences Inc.
                       6.1.1. Company Overview
                       6.1.2. Financial Performance
                       6.1.3. Product Benchmarking
                       6.1.4. Strategic Initiatives
                    6.2. Bayer AG
                       6.2.1. Company Overview
                       6.2.2. Financial Performance
                       6.2.3. Product Benchmarking
                       6.2.4. Strategic Initiatives
                    6.3. Cristalia Produtos Quimicos Farmaceuticos Ltd.
                       6.3.1. Company Overview
                       6.3.2. Financial Performance
                       6.3.3. Product Benchmarking
                       6.3.4. Strategic Initiatives
                    6.4. Dong-A Pharmaceutical Co. Ltd.
                       6.4.1. Company Overview
                       6.4.2. Financial Performance
                       6.4.3. Product Benchmarking
                       6.4.4. Strategic Initiatives
                    6.5. Eli Lilly and Company
                       6.5.1. Company Overview
                       6.5.2. Financial Performance
                       6.5.3. Product Benchmarking
                       6.5.4. Strategic Initiatives
                    6.6. Meda Pharmaceuticals, Inc.
                       6.6.1. Company Overview
                       6.6.2. Financial Performance
                       6.6.3. Product Benchmarking
                       6.6.4. Strategic Initiatives
                    6.7. Pfizer, Inc.
                       6.7.1. Company Overview
                       6.7.2. Financial Performance
                       6.7.3. Product Benchmarking
                       6.7.4. Strategic Initiatives
                    6.8. S.K. Chemicals Co. Ltd.
                       6.8.1. Company Overview
                       6.8.2. Financial Performance
                       6.8.3. Product Benchmarking
                       6.8.4. Strategic Initiatives
                    6.9. Vivus, Inc.
                       6.9.1. Company Overview
                       6.9.2. Financial Performance
                       6.9.3. Product Benchmarking
                       6.9.4. Strategic Initiatives


List of Tables

1. Erectile dysfunction drugs - Industry snapshot
2. Erectile dysfunction drugs market , by product, 2012 - 2022 (USD million)
3. Erectile dysfunction drugs market , by region, 2012 - 2022 (USD million)
4. Erectile dysfunction drugs market - Key market drivers analysis
5. Erectile dysfunction drugs market - Key market restraints analysis
6. North America erectile dysfunction drugs market , by Product, 2012 - 2022 (USD million)
7. Europe erectile dysfunction drugs market, by product, 2012 - 2022 (USD million)
8. Asia Pacific Erectile dysfunction drugs market, by product, 2012 - 2022 (USD million)
9. Latin America erectile dysfunction drugs market , by product, 2012 - 2022 (USD million)
10. MEA erectile dysfunction drugs market , by product, 2012 - 2022 (USD million)


List of Figures

1. Erectile dysfunction drugs market segmentation
2. Global erectile dysfunction drugs market revenue, 2012 - 2022
3. Erectile dysfunction drugs market dynamics
4. Key opportunities prioritized
5. Erectile dysfunction drugs market analysis - Porter's
6. Erectile dysfunction drugs market analysis – PESTEL Analysis
7. Global erectile dysfunction drugs market , By product, 2012 - 2022 (USD million)
8. Viagra (sildenafil citrate) market, 2012 - 2022 (USD million)
9. Cialis (tadalafil) Market, 2012 - 2022 (USD million)
10. Levitra/ staxyn (Vardenafil) market, 2012 - 2022 (USD million)
11. Stendra/Spedra (avanafil) market, 2012 - 2022 (USD million)
12. Zydena (udenafil) market, 2012 - 2022 (USD million)
13. Vitaros (alprostadil) market, 2012 - 2022 (USD million)
14. Others market, 2012 - 2022 (USD million)
15. Global erectile dysfunction drugs market , By region 2012 to 2022 (USD million)
16. North America market, by product 2012 to 2022 (USD million)
17. Europe market, by product 2012 to 2022 (USD million)
18. Asia Pacific market, by product 2012 to 2022 (USD million)
19. Latin America market, by product 2012 to 2022 (USD million)
20. MEA market, by product 2012 to 2022 (USD million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.